Earnings History Data for Chembio Diagnostics, Inc. (CEMI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Chembio Diagnostics, Inc.
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 03-11-2022 | AH | 4:05 PM ET (Nov 3) |
CEMI | Chembio Diagnostics, Inc. | 10.73 | -0.21 | 0.00 | -0.23 | Chembio Diagnostics GAAP EPS of -$0.21, revenue of $11.2M [11/3/2022 4:36 PM] |
0.3244 | -0.03 (-8.10%) |
0.36 | 0.01 (1.93%) |
0.25 - 2.47 | 460,666 | 400,000 | 6,508 | |
| 04-08-2022 | AH | 4:05 PM ET (Aug 4) |
CEMI | Chembio Diagnostics, Inc. | 21.76 | -0.23 | 0.00 | -0.35 | Chembio Diagnostics GAAP EPS of -$0.23, revenue of $9.2M [8/4/2022 4:15 PM] |
1.10 | 0.02 (1.85%) |
0.89 | -0.19 (-17.79%) |
0.42 - 3.55 | 3,049,093 | 3,710,000 | 260,556 | |
| 05-05-2022 | AH | 4:05 PM ET (May 5) |
CEMI | Chembio Diagnostics, Inc. | 17.29 | -0.29 | 0.00 | -0.22 | Chembio Diagnostics GAAP EPS of -$0.29 misses by $0.08, revenue of $18.82M beats by $7.02M [5/5/2022 4:19 PM] |
0.5579 | -0.11 (-16.61%) |
0.60 | -0.07 (-10.54%) |
0.53 - 7.34 | 262,947 | 160,000 | 874 | |
| 03-03-2022 | AH | 4:05 PM ET (Mar 3) |
CEMI | Chembio Diagnostics, Inc. | 28.86 | -0.32 | -0.23 | -0.35 | Chembio Diagnostics GAAP EPS of $0.47 beats by $0.67, revenue of $20.6M beats by $7.05M [3/3/2022 4:11 PM] |
0.7993 | -0.12 (-13.30%) |
0.82 | -0.10 (-11.05%) |
0.79 - 7.34 | 714,087 | 360,000 | 62,530 | |
| 04-11-2021 | AH | 4:05 PM ET (Nov 4) |
CEMI | Chembio Diagnostics, Inc. | 66.98 | -0.23 | -0.21 | -0.28 | Chembio Diagnostics EPS misses by $0.04, beats on revenue [11/4/2021 4:32 PM] |
2.13 | -0.31 (-12.86%) |
2.17 | -0.28 (-11.43%) |
2.06 - 8.75 | 2,007,983 | 950,000 | 148,576 | |
| 05-08-2021 | AH | 4:05 PM ET (Aug 5) |
CEMI | Chembio Diagnostics, Inc. | 71.44 | -0.35 | -0.38 | -0.40 | Chembio Diagnostics EPS misses by $0.04, misses on revenue [8/5/2021 5:05 PM] |
3.00 | -0.52 (-14.77%) |
3.00 | -0.52 (-14.77%) |
2.06 - 8.75 | 6,632,558 | 15,360,000 | 590,215 | |
| 06-05-2021 | AH | 4:05 PM ET (May 6) |
CEMI | Chembio Diagnostics, Inc. | 74.07 | -0.22 | -0.30 | -0.25 | Chembio Diagnostics EPS beats by $0.10, beats on revenue [5/6/2021 4:28 PM] |
3.43 | -0.07 (-2.00%) |
3.45 | -0.05 (-1.43%) |
3.01 - 13.33 | 518,482 | 490,000 | 5,603 | |
| 11-03-2021 | AH | 4:05 PM ET (Mar 11) |
CEMI | Chembio Diagnostics, Inc. | 96.04 | -0.35 | 0.00 | -0.23 | Chembio Diagnostics EPS misses by $0.07, beats on revenue [3/11/2021 4:21 PM] |
4.32 | -0.62 (-12.65%) |
4.40 | -0.54 (-10.93%) |
2.25 - 15.89 | 1,045,229 | 836,542 | 36,846 | |
|
||||||||||||||||||
| 05-11-2020 | AH | 4:05 PM ET (Nov 5) |
CEMI | Chembio Diagnostics, Inc. | 92.14 | -0.28 | -0.24 | -0.22 | Chembio Diagnostics EPS misses by $0.02, beats on revenue [11/5/2020 5:16 PM] |
4.74 | 0.30 (6.88%) |
4.76 | 0.33 (7.45%) |
2.25 - 15.89 | 1,111,903 | 1,170,694 | 47,333 | |
|
|
||||||||||||||||||
| 06-08-2020 | AH | 4:05 PM ET (Aug 6) |
CEMI | Chembio Diagnostics, Inc. | 118.39 | -0.40 | -0.33 | -0.19 | Chembio Diagnostics EPS misses by $0.02, beats on revenue [8/6/2020 4:53 PM] |
5.30 | -0.14 (-2.57%) |
4.90 | -0.54 (-9.93%) |
2.25 - 15.89 | 3,175,444 | 5,560,557 | 430,425 | |
|
|
||||||||||||||||||